Patent details
EP4125881 Title: NEW USE OF ANGIOTENSIN II TYPE 2 RECEPTOR AGONIST
Basic Information
- Publication number:
- EP4125881
- PCT Application Number:
- GB2021050699
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP217153063
- PCT Publication Number:
- WO2021191592
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- NEW USE OF ANGIOTENSIN II TYPE 2 RECEPTOR AGONIST
- French Title of Invention:
- NOUVELLE UTILISATION D'UN AGONISTE DES RÉCEPTEURS DE L'ANGIOTENSINE 2 DE TYPE II
- German Title of Invention:
- NEUE VERWENDUNG EINES ANGIOTENSIN II-TYP 2-REZEPTORAGONISTEN
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 21/08/2041
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 26/08/2024
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 24/07/2024
- Unitary Effect Registration Date:
- 26/08/2024
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 22/03/2021
- Grant date:
- 24/07/2024
- EP Publication Date:
- 08/02/2023
- PCT Publication Date:
- 30/08/0014
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 24/07/2024
- EP B1 Publication Date:
- 24/07/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 22/03/2041
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 17/07/2024
- Name:
- Vicore Pharma AB
- Address:
- Kornhamnstorg 53, 111 27 Stockholm, Sweden (SE)
Inventor
1
- Name:
- BATTA, Rohit
- Address:
- Sweden (SE)
2
- Name:
- DALSGAARD, Carl-Johan
- Address:
- Sweden (SE)
3
- Name:
- RAUD, Johan
- Address:
- Sweden (SE)
Priority
1
- Priority Number:
- 202004209
- Priority Date:
- 23/03/2020
- Priority Country:
- United Kingdom (GB)
2
- Priority Number:
- 202009574
- Priority Date:
- 23/06/2020
- Priority Country:
- United Kingdom (GB)
3
- Priority Number:
- 202017113416
- Priority Date:
- 07/12/2020
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/4178; A61K 31/573; A61K 31/706; A61K 38/21; A61K 45/06; A61P 31/14;
Publication
European Patent Bulletin
1
- Issue number:
- 202430
- Publication date:
- 24/07/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202438
- Publication date:
- 18/09/2024
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202439
- Publication date:
- 25/09/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|